AUA/SUO Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer Guideline Summary - Guideline Central

Design and created by Guideline Central in participation with the American Urological Association and Society of Urologic Oncology.

Document Overview

Document Title: Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer

Authoring Societies

American Urological Association

Society of Urologic Oncology

Document Publication Date: Jan 24, 2024

Page Last Reviewed/Updated: May 6, 2026

Document Type: Guideline

Country of Publication: United States

Full Text Freely Available: Yes

Full Text Guideline: www.auajournals.org/doi/10.1097/JU.0000000000003846

Source Citation: Holzbeierlein JM, Bixler BR, Buckley DI, Chang SS, Holmes R, James AC, Kirkby E, McKiernan JM, Schuckman AK. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment. J Urol. 2024 Jan 24:101097JU0000000000003846. doi: 10.1097/JU.0000000000003846. Epub ahead of print. PMID: 38265030.

Supplemental Implementation Resources

Document Scope, Criteria, and Use Cases

Document Objectives: This guideline attempts to provide a clinical framework for the management of NMIBC.

Scope: Diagnosis, Treatment

Diseases/Conditions (MeSH)

D001743 - Urinary Bladder

D001749 - Urinary Bladder Neoplasms

D001743 - Urinary Bladder

D001749 - Urinary Bladder Neoplasms

Keywords: Cystectomy, Neoplasm, Urinary bladder, bladder cancer, immunotherapy

Inclusion Criteria: Male, Female, Adolescent, Adult, Older Adult

Health Care Settings: Hospital, Operating and Recovery Room, Outpatient

Intended Users: Nurse, Nurse Practitioner, Physician, Physician Assistant, Radiology Technologist

Recommendation Development Processes & Methodology

Number of Source Documents: 278

Literature Search Start Date: Monday, January 1, 1990

Literature Search End Date: Monday, May 1, 2023

Includes peer/external review process?: Yes

Includes public comment process?: No

Methodologist involvement?: Yes

Patient involvement?: No

Includes multi-disciplinary group?: Yes

Includes systematic review?: Yes

Grades quality of strength of evidence?: Yes

Grades quality of strength of recommendation?: Yes

Discloses funding source?: Yes

Discloses conflicts of interest?: No

Includes benefits/harms analysis with recommendations?: Yes